Phio Pharmaceuticals Corp.https://pcaobus.org/form-ap-filings/37210/37210Phio Pharmaceuticals Corp.372103/28/2019 7:47:10 PM201879d5e923-ec34-4d06-8ae6-7b434e3a1f5d243BDO USA, LLP728393Phio Pharmaceuticals Corp.1533040PHIO; PHIOW0024311029Catherine Mary Moy0024311029True
RXi Pharmaceuticals Corporationhttps://pcaobus.org/form-ap-filings/21095/21095RXi Pharmaceuticals Corporation210953/30/2018 1:39:46 PM201716cd18b7-2b40-42c0-909a-0aa686c14723243BDO USA, LLP517880RXi Pharmaceuticals Corporation1533040PHIO; PHIOW0024311029Catherine Mary Moy0024311029True
Nuance Communications, Inc.https://pcaobus.org/form-ap-filings/14722/14722Nuance Communications, Inc.1472212/12/2017 4:31:10 PM2017b8ca93c8-93d7-46aa-aab1-3edd3b77ca91243BDO USA, LLP67505Nuance Communications, Inc.1002517NUAN0024311029Catherine Mary Moy0024311029True
Cyalume Technologies Holdings, Inc.https://pcaobus.org/form-ap-filings/4702/4702Cyalume Technologies Holdings, Inc.47023/30/2017 7:02:20 PM2016ad153941-c912-44bc-8ab4-fed90eec2043243BDO USA, LLP322311Cyalume Technologies Holdings, Inc.1335293CYLU0024311029Catherine Mary Moy0024311029True
RXi Pharmaceuticals Corporationhttps://pcaobus.org/form-ap-filings/4697/4697RXi Pharmaceuticals Corporation46973/30/2017 7:02:20 PM20163e57d547-2262-4b01-9add-c08d07e5738f243BDO USA, LLP517880RXi Pharmaceuticals Corporation1533040PHIO; PHIOW0024311029Catherine Mary Moy0024311029True